Physician

Shylaja Mani, MD

According to 2025 Medicare claims, Shylaja Mani, MD (NPI: 1891052205) practices hematology/oncology in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is COLUMBUS ONCOLOGY ASSOCIATES INC (NPI: 1790875656; TIN: 311211874) and primary practice location at 43214-4359. Mani is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Mani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 248 traditional Medicare patients, billed 68,385 HCPCS/CPT codes, and received $1,331,559 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,212 prescription claims across 187 beneficiaries totaling $2,949,019 in drug costs, led by Calquence (Acalabrutinib Maleate). 2023 DME data shows 24 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $4,589 to $1,331,559. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,445 to $2,949,019. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	31	62	$4,589
2016	43	90	$7,548
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	50	105	$8,236
2020	202	611	$45,015
2021	274	934	$84,876
2022	324	16,431	$240,833
2023	264	58,454	$1,252,472
2024	248	68,385	$1,331,559

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	22	86	$2,445
2016	N/R	N/R	N/R
2017	21	47	$584
2018	N/R	19	$313
2019	23	70	$13,357
2020	121	714	$636,184
2021	195	1,418	$2,039,145
2022	217	1,206	$2,042,923
2023	164	718	$1,548,109
2024	187	1,212	$2,949,019

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	32	$1,379
2021	N/R	93	$3,103
2022	N/R	77	$2,035
2023	N/R	24	$8,447
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	61	185	$128
96413	Administration of chemotherapy into vein, 1 hour or less	51	192	$91
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	133	316	$90
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	135	321	$12
96375	Injection of additional new drug or substance into vein	36	155	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Calquence	Acalabrutinib Maleate	39	1,170	$588,761
Ibrance	Palbociclib	31	868	$481,079
Revlimid	Lenalidomide	23	644	$394,677
Tagrisso	Osimertinib Mesylate	23	690	$379,003
Cabometyx	Cabozantinib S-Malate	14	420	$367,655

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Shylaja Mani, MD?

Tedicare shows public-source Medicare data for Shylaja Mani, MD (NPI 1891052205), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shylaja Mani, MD have ACO affiliation data?

Shylaja Mani, MD is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Shylaja Mani, MD?

Shylaja Mani, MD is linked to COLUMBUS ONCOLOGY ASSOCIATES INC (billing NPI 1790875656) in the available physician profile data.

Does Shylaja Mani, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.